FOLR1 and non-small cell lung carcinoma: In the case of NSCLC, TAAs that are interesting for use in clinical areas include alpha folate receptors (FRα), mucin 1, and the transforming growth factor-beta receptor (Kalli et al., 2008; Furler et al., 2018; Syrkina et al., 2019).